ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Biosample Name	Biosample Description	Species	Strain	Cancer Type
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833875	GSE64771	Orthotopic Tumor	GSM1580364	None	Androgen Sensitive Primary Orthotopic Tumor (RS-01574311)	None	Mouse	Androgen Sensitive Primary Orthotopic Tumor (RS-01574311)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833876	GSE64771	Orthotopic Tumor	GSM1580365	None	Androgen Sensitive Met (matched) (RS-01574312)	None	Mouse	Androgen Sensitive Met (matched) (RS-01574312)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833873	GSE64771	Orthotopic Tumor	GSM1580362	None	Androgen Sensitive Primary Orthotopic Tumor (RS-01574309)	None	Mouse	Androgen Sensitive Primary Orthotopic Tumor (RS-01574309)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833879	GSE64771	Orthotopic Tumor	GSM1580368	None	Castrate Resistant Primary Orthotopic Tumor (RS-01580059)	None	Mouse	Castrate Resistant Primary Orthotopic Tumor (RS-01580059)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833874	GSE64771	Orthotopic Tumor	GSM1580363	None	Androgen Sensitive Met (matched) (RS-01574310)	None	Mouse	Androgen Sensitive Met (matched) (RS-01574310)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833878	GSE64771	Orthotopic Tumor	GSM1580367	None	Castrate Resistant Met (matched) (RS-01580058)	None	Mouse	Castrate Resistant Met (matched) (RS-01580058)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833880	GSE64771	Orthotopic Tumor	GSM1580369	None	Castrate Resistant Met (matched) (RS-01580060)	None	Mouse	Castrate Resistant Met (matched) (RS-01580060)	Prostate_Adenocarcinoma
GSE64771	25605014	Top2a identifies and provides epigenetic rationale for novel combinationtherapeutic strategies for aggressive prostate cancer.	None	SRX833877	GSE64771	Orthotopic Tumor	GSM1580366	None	Castrate Resistant Primary Orthotopic Tumor (RS-01580057)	None	Mouse	Castrate Resistant Primary Orthotopic Tumor (RS-01580057)	Prostate_Adenocarcinoma
